{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T09:10:53Z","timestamp":1782983453251,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12678-9","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T17:02:29Z","timestamp":1722358949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Alfalfa-inpatient-CAT assessment model: a thrombotic risk assessment model for inpatient cancer patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenjun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiguang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meina","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"issue":"3","key":"12678_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s11239-018-1610-9","volume":"45","author":"A Kuperman","year":"2018","unstructured":"Kuperman A, L\u00f3pez-Reyes R, Bosco LJ, et al. Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism. J Thromb Thrombolysis. 2018;45(3):360\u20138.","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"12678_CR2","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","volume":"122","author":"JF Timp","year":"2013","unstructured":"Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;122(10):1712\u201323.","journal-title":"Blood"},{"issue":"14","key":"12678_CR3","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood.2020007338","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder FI, Horv\u00e1th-Puh\u00f3 E, van Es N, et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2021;137(14):1959\u201369.","journal-title":"Blood"},{"key":"12678_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0049-3848(10)00227-6","volume":"125 Suppl 2","author":"GC Connolly","year":"2010","unstructured":"Connolly GC, Khorana AA. Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score. Thromb Res. 2010;125 Suppl 2:S1\u20137.","journal-title":"Thromb Res"},{"issue":"2\u20133","key":"12678_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.disamonth.2005.02.003","volume":"51","author":"JA Caprini","year":"2005","unstructured":"Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51(2\u20133):70\u20138.","journal-title":"Dis Mon"},{"issue":"10","key":"12678_CR6","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902\u20137.","journal-title":"Blood"},{"issue":"11","key":"12678_CR7","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","volume":"8","author":"S Barbar","year":"2010","unstructured":"Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450\u20137.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"12678_CR8","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1111\/jth.13378","volume":"14","author":"AS Mansfield","year":"2016","unstructured":"Mansfield AS, Tafur AJ, Wang CE, Kourelis TV, Wysokinska EM, Yang P. Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer. J Thromb Haemost. 2016;14(9):1773\u20138.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"12678_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12032-018-1120-9","volume":"35","author":"J Rupa-Matysek","year":"2018","unstructured":"Rupa-Matysek J, Lembicz M, Rogowska EK, Gil L, Komarnicki M, Batura-Gabryel H. Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients. Med Oncol. 2018;35(5):63.","journal-title":"Med Oncol"},{"issue":"14","key":"12678_CR10","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJMcp067264","volume":"356","author":"CW Francis","year":"2007","unstructured":"Francis CW. Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients. N Engl J Med. 2007;356(14):1438\u201344.","journal-title":"N Engl J Med"},{"issue":"7","key":"12678_CR11","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1182\/blood-2008-02-142422","volume":"112","author":"C Ay","year":"2008","unstructured":"Ay C, Simanek R, Vormittag R, et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood. 2008;112(7):2703\u20138.","journal-title":"Blood"},{"issue":"12","key":"12678_CR12","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1111\/j.1538-7836.2005.01621.x","volume":"3","author":"F Piovella","year":"2005","unstructured":"Piovella F, Wang CJ, Lu H, et al. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost. 2005;3(12):2664\u201370.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"12678_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nchembio.496","volume":"7","author":"A Hakkim","year":"2011","unstructured":"Hakkim A, Fuchs TA, Martinez NE, et al. Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat Chem Biol. 2011;7(2):75\u20137.","journal-title":"Nat Chem Biol"},{"issue":"04","key":"12678_CR14","first-page":"434","volume":"51","author":"Z Yinping","year":"2016","unstructured":"Yinping Z, Yan C, Zhihui Q, et al. Risk factors for picC-associated deep vein thrombosis in upper extremity in patients with lung cancer undergoing chemotherapy. Chin J Nurs. 2016;51(04):434\u20137.","journal-title":"Chin J Nurs"},{"issue":"005","key":"12678_CR15","first-page":"804","volume":"023","author":"H Yuan","year":"2017","unstructured":"Yuan H, Qian C, Huang Y. The relationship between hypertension and deep vein thrombosis in lower extremity. J Thromb Hemost. 2017;023(005):804\u20136.","journal-title":"J Thromb Hemost"},{"issue":"11","key":"12678_CR16","first-page":"1214","volume":"26","author":"Y Guo","year":"2019","unstructured":"Guo Y, Hu L, Wang M. Relationship between venous thrombosis and blood coagulation in patients with peripheral venous catheterization. Chin J Clin Oncol. 2019;26(11):1214\u20137.","journal-title":"Chin J Clin Oncol"},{"issue":"1","key":"12678_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1538-7836.2010.04069.x","volume":"9","author":"R Kanz","year":"2011","unstructured":"Kanz R, Vukovich T, Vormittag R, et al. Thrombosis risk and survival in cancer patients with elevated C-reactive protein. J Thromb Haemost. 2011;9(1):57\u201363.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"12678_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.36290\/vnl.2020.153","volume":"66","author":"D Musil","year":"2020","unstructured":"Musil D. Acute infections, venous thrombosis, and recommended thromboprophylaxis. Vnitr Lek. 2020;66(8):17\u201323 Winter, English.","journal-title":"Vnitr Lek"},{"key":"12678_CR19","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1200\/JCO.2009.22.3271","volume":"27","author":"AA Khorana","year":"2009","unstructured":"Khorana AA, Connolly GC. Assessing risk of venous throm-boembolism in the patient with cancer. J Clin Oncol. 2009;27:4839\u201347.","journal-title":"J Clin Oncol"},{"key":"12678_CR20","doi-asserted-by":"publisher","first-page":"e1001275","DOI":"10.1371\/journal.pmed.1001275","volume":"9","author":"F Horsted","year":"2012","unstructured":"Horsted F, West J, Grainge MJ, et al. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med. 2012;9:e1001275.","journal-title":"PLoS Med"},{"key":"12678_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/sj.bjc.6605883","volume":"103","author":"DP Cronin-Fenton","year":"2010","unstructured":"Cronin-Fenton DP, S\u00f8ndergaard F, Pedersen LA. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997\u20132006. Br J Cancer. 2010;103:947.","journal-title":"Br J Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12678-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12678-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12678-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T17:04:03Z","timestamp":1722359043000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12678-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12678"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12678-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]},"assertion":[{"value":"13 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complies with the Declaration of Helsinki and was authorized by The Ethics Committee of Fujian Medical University Union Hospital. The requirement for patient consent was waived due to its retrospective nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"919"}}